WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Fady Ibraham MalikEVP Research Development2024-04-0928,605$74.31
$2.13MSell
Fady Ibraham MalikEVP Research Development2024-04-094,000$74.32
$297.28kSell
Fady Ibraham MalikEVP Research Development2024-04-0928,605$6.67
$190.80kBuy
Fady Ibraham MalikEVP Research Development2024-03-068,109$66.88
$542.33kSell
Robert WongVP Chief Accounting Officer2024-03-06857$66.88
$57.32kSell
Robert I. BlumPresident CEO2024-03-0616,725$66.88
$1.12MSell
Andrew CallosEVP Chief Commercial Officer2024-03-065,103$66.88
$341.29kSell
Fady Ibraham MalikEVP Research Development2024-03-054,000$67.53
$270.12kSell
Fady Ibraham MalikEVP Research Development2024-03-0528,604$6.67
$190.79kBuy
Fady Ibraham MalikEVP Research Development2024-03-0528,604$67.56
$1.93MSell

1 of 11

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.63%16,102,070$1.06BInstitution
Fmr LLC12.63%13,007,783$852.92MInstitution
Vanguard Group Inc10.70%11,016,889$722.38MInstitution
Michael Schmertzler9.45%9,730,131$638.00MInsider
Wellington Management Group LLP6.30%6,488,500$425.45MInstitution
State Street Corp5.72%5,893,358$386.43MInstitution
Price T Rowe Associates Inc3.15%3,244,250$212.73MInstitution
Eastern Capital Ltd2.80%2,883,845$189.09MInsider
Janus Henderson Group PLC2.49%2,568,405$168.41MInstitution
Rtw Investments LP2.45%2,525,080$165.57MInstitution

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK88.31%11.69%Net SellingNet Selling
JAZZ26.94%73.06%Net SellingNet Selling
EXEL85.28%4.07%Net SellingNet Buying
VKTX75.97%9.93%Net SellingNet Selling
PCVX83.78%16.22%Net BuyingNet Buying
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 110.53% institutional shareholders, 14.63% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 9.45% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $650.17M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.